Infection risk score after liver transplant
Treatments studied
Part of Digestive system, Infections clinical trials.
This study develops a score to predict infection risk right after a liver transplant. It uses blood samples from transplant day to identify which patients are more likely to get infections, helping doctors tailor care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are waiting for a liver transplant due to cirrhosis, liver cancer, acute liver failure, or other listed conditions.
- You will actually receive a liver transplant during the study.
- You agree to take part and provide a blood sample on the day of your transplant.
- You are 18 years or older.
- You are not pregnant or breastfeeding.
- You have not taken immune-suppressing drugs (other than specific steroids for alcoholic hepatitis) before the transplant.
- You are not having a multi-organ transplant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at what types of germs (bacteria, viruses, etc.) cause infections in people after a liver transplant. By understanding these germs, doctors hope to better prevent and treat infections, which could help you recover more smoothly.
This study looks at blood markers of the immune system to see if they can predict complications after a liver transplant. It aims to help doctors personalize care and catch problems early.
This study looks at how blood sugar levels change during liver transplant surgery and whether those changes are linked to infections afterward. If you join, researchers will track your blood sugar during the operation and watch for infections after, which may help improve care for future patients.
This study looks at whether different scoring tools can better predict outcomes for people with cirrhosis who are waiting for a liver transplant. It may help improve how transplant urgency is decided.
This study follows people who are getting a liver transplant (including repeat transplants) to monitor changes in their body using test results. It may help doctors understand how patients are doing after transplant and improve care over time.
This trial is testing a new way to see how well patients do after a liver transplant. It includes people with severe cirrhosis, other end-stage liver diseases, or liver cancer.
Hear when a new Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.